Literature DB >> 7764878

Production of anti-tumour-promoting furanonaphthoquinones in Tabebuia avellanedae cell cultures.

S Ueda1, T Umemura, K Dohguchi, T Matsuzaki, H Tokuda, H Nishino, A Iwashima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7764878     DOI： 10.1016/s0031-9422(00)97069-9

Source DB:  PubMed          Journal:  Phytochemistry        ISSN： 0031-9422            Impact factor:   4.072


× No keyword cloud information.
  6 in total

1.  Antinociceptive and antiedematogenic properties and acute toxicity of Tabebuia avellanedae Lor. ex Griseb. inner bark aqueous extract.

Authors:  F G de Miranda; J C Vilar; I A Alves; S C Cavalcanti; A R Antoniolli
Journal:  BMC Pharmacol       Date:  2001-09-13

2.  A new and efficient procedure for the synthesis of hexahydropyrimidine-fused 1,4-naphthoquinones.

Authors:  Marcelo Isidoro P Reis; Vinícius R Campos; Jackson A L C Resende; Fernando C Silva; Vitor F Ferreira
Journal:  Beilstein J Org Chem       Date:  2015-07-22       Impact factor: 2.883

3.  Tabetri™ (Tabebuia avellanedae Ethanol Extract) Ameliorates Osteoarthritis Symptoms Induced by Monoiodoacetate through Its Anti-Inflammatory and Chondroprotective Activities.

Authors:  Jae Gwang Park; Young-Su Yi; Yo Han Hong; Sulgi Yoo; Sang Yun Han; Eunji Kim; Seong-Gu Jeong; Adithan Aravinthan; Kwang Soo Baik; Su Young Choi; Young-Jin Son; Jong-Hoon Kim; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2017-11-26       Impact factor: 4.711

4.  Oral administration of taheebo (Tabebuia avellanedae Lorentz ex Griseb.) water extract prevents DSS-induced colitis in mice by up-regulating type II T helper immune responses.

Authors:  Hyun Jung Park; Sung Won Lee; Dong-Joo Kwon; Seong-Il Heo; Se-Ho Park; Sun Young Kim; Seokmann Hong
Journal:  BMC Complement Altern Med       Date:  2017-09-06       Impact factor: 3.659

5.  Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis.

Authors:  Eliezer Menezes Pereira; Thelma de Barros Machado; Ivana Correa Ramos Leal; Desyreé Murta Jesus; Clarissa Rosa de Almeida Damaso; Antonio Ventura Pinto; Marcia Giambiagi-deMarval; Ricardo Machado Kuster; Kátia Regina Netto dos Santos
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-03-22       Impact factor: 3.944

6.  β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers.

Authors:  Yang Yang; Xianchun Zhou; Ming Xu; Junjie Piao; Yuan Zhang; Zhenhua Lin; Liyan Chen
Journal:  Sci Rep       Date:  2017-06-02       Impact factor: 4.996
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.